Bayer Says Cipla's Blood-Thinner Infringes Xarelto Patent
Bayer AG is pushing back at a recent bid from Indian rival Cipla Ltd. to nix a patent for Bayer's blood thinner Xarelto, claiming that Cipla merely seeks to invalidate the...To view the full article, register now.
Already a subscriber? Click here to view full article